BDBM62630 2-[4-(1-phenyltetrazol-5-yl)oxyphenyl]-1,3,4-oxadiazole::2-[4-[(1-phenyl-1,2,3,4-tetrazol-5-yl)oxy]phenyl]-1,3,4-oxadiazole::2-[4-[(1-phenyl-5-tetrazolyl)oxy]phenyl]-1,3,4-oxadiazole::MLS000058476::SMR000068063::cid_2526141

SMILES O=C(O)c1ccc(N2CCOc3cc(C(=O)N4CCCCC4)c(Cl)cc32)cc1

InChI Key InChIKey=VLHXRYVJTGASCS-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 62630   

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 62630BDBM62630(US12577217, Example 2-3)
Affinity DataIC50: 10nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent